Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 55,780 shares at $32.07 ($1.8M) on 2023-11-14, disclosed to the SEC on 2023-11-16.
Scheduled sale ($1.8M) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.07 | 27,890 | $894K | 50.0% |
| 2 | $32.07 | 27,890 | $894K | 50.0% |
| Total | $32.07 avg | 55,780 | $1.8M | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |